|

Androgen receptor signaling inhibitor (ARSI) Clinical Trials

2 actively recruiting trials across 2 locations

▲ +1 trial since August 2026

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • Case Comprehensive Cancer Center1
  • Astellas Pharma Global Development, Inc.1

Indications

  • Cancer2
  • Hormone-refractory Prostate Cancer1
  • Secondary Malignant Neoplasm of Prostate1
  • Malignant Neoplasm of Prostate1
  • Prostate Cancer1

Orange, California1 trial

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

UCI Health Chao Family Comprehensive Cancer Center

Phase 1

New York, New York1 trial

MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)

Memorial Sloan Kettering Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.